Sumitomo Pharma Co Ltd
OTC:DNPUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
OTC:DNPUF
|
JP |
|
B
|
Bin Ulasim ve Akilli Sehir Teknolojileri AS
IST:BINBN.E
|
TR |
|
Cikarang Listrindo Tbk PT
F:B2O
|
ID |
|
K
|
KALA BIO Inc
XMUN:27F0
|
US |
Wall St Price Targets
DNPUF Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for DNPUF is 12.365 USD with a low forecast of 8.816 USD and a high forecast of 16.497 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DNPUF's stock price target?
Price Target
12.365
USD
According to Wall Street analysts, the average 1-year price target for DNPUF is 12.365 USD with a low forecast of 8.816 USD and a high forecast of 16.497 USD.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-26%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is -26%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
84%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 84%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 48%.
